What is West Pharmaceutical Services EBIT per Share?
West Pharmaceutical Services's EBIT per Share for the
three
months ended in Mar. 2024 was $1.74.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $9.01.
During the past 12 months, the average EBIT per Share Growth Rate of West Pharmaceutical Services was -6.40% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 19.30% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 28.40% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 18.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for West Pharmaceutical Services's EBIT per Share or its related term are showing as below:
WST'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -10.5 Med: 8.4 Max: 45.8
Current: 19.3
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of West Pharmaceutical Services was 45.80% per year. The lowest was -10.50% per year. And the median was 8.40% per year.
WST's 3-Year EBIT Growth Rate is ranked better than 65.01% of 723
companies
in the Medical Devices & Instruments industry
Industry Median: 6.7
vs WST: 19.30
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
West Pharmaceutical Services (NYSE:WST) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
West Pharmaceutical Services EBIT per Share Related Terms
Thank you for viewing the detailed overview of West Pharmaceutical Services's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
West Pharmaceutical Services (West Pharmaceutical Services) Business Description
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WST has been successfully added to your 